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Abstract: Lipid metabolism is closely related to the occurrence and development of various diseases, and microRNAs, 
as important post-transcriptional regulatory factors, are involved in various biological processes of adipocyte differen-
tiation and lipid metabolism to regulate lipid metabolism. In this paper, the effects of miRNAs on adipocyte differentia-
tion, lipid synthesis, decomposition and transport reported in recent years are reviewed, with the hope of promoting the 
mechanism of microRNA in lipid metabolism disorders.
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Introduction	
Lipid metabolism is one of the three major metabolisms of the body, which is of great significance for the 
maintenance of energy, physiological function and regulation of the body. The regulatory process of lipid metabolism 
is mainly related to the formation and differentiation of adipocytes, lipid synthesis, decomposition and transport. 
MicroRNAs (miRNAs for short) are endogenous, highly conserved single-stranded non-coding RNAs with a size of 
about 18-25 nucleotides. Since the discovery of miRNAs[1], their relationship with diseases has attracted increasing 
attention. Up to now, miRNAs have been proved to be involved in many complex physiological processes in organisms, 
such as lipid metabolism. Oxidative stress. Current studies have found that miRNAs are closely related to various 
processes of lipid metabolism.
1.MiRNA	and	adipocyte	differentiation
At present, it is generally believed that adipocytes are gradually differentiated from mesenchymalstem cells (MSC) 
from the mesoderm, through APC, preadipocytes, immature adipocytes, and finally mature adipocytes.Many studies 
have shown that adipocyte differentiation regulates lipid metabolism,and microRNAs[2] seem to play an important role 
in adipocyte differentiation.
Asha [3] reported the role of miR-26 family (miR-26a-1, miR-26a-2 and miR-26b) in regulating the differentiation 
of adipocytes into new adipocytes and adipose tissue quality. In vivo experiments, mice were deletions of all miR-26 
coding sites in vivo, resulting in significant dilation of adipose tissue in adult animals fed a normal diet. In contrast, 
overexpression of miR-26a in mice protected the mice from high-fat diet-induced obesity.
Xu[4] found that miRNA-16-5p was significantly up-regulated during the differentiation of 3T3-L1 preadipocytes 
to mature adipocytes, and the overexpression of miRNA-16-5p led to the promotion of mature adipocyte-specific gene 
expression and fat droplet accumulation in vitro and in vivo.EPT1 was also identified as the target gene of miRNA-16-
5p.Martinelli[5] showed that miR-519d specifically and in a dose-dependent manner inhibited the translation of PPARA 
protein and increased lipid accumulation during preadipocyte differentiation. The 30-UTR of PPARA contains a putative 
miRNA binding site that has been shown to bind specifically to miR-519d.
Zhang [5] pointed out that miRNA-200a plays an important role in promoting adipocyte differentiation in yaks in 
their study on the relationship between miRNAs and adipocyte differentiation in domesticated yaks, and miRNA-200a 
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can also lead to lipid accumulation in transfection adipocytes. The results also showed that miR-200a increased the 
expression of adipocyte-specific genes such as PPARγ, ELVOL and C/EBPα.
2.	MiRNAs	and	lipid	synthesis
Lipid mainly includes fats, sterols and lipids, while fats refer to triglycerides, which are synthesized by a molecule 
of glycerol and three molecules of fatty acids. Triglycerides account for the vast majority of human lipids. Triglyceride 
molecules represent the main form of storage and transport of fatty acids in cells and plasma. Liver [6] is the central 
organ of fatty acid synthesis. Fatty acids accumulate in the liver through uptake by liver cells from plasma and de novo 
biosynthesis.
MiR-122 is not only the first known miRNA to regulate lipid metabolism, but also a tissue-specific miRNA. 
Systemic or liver miR-122 deletion showed significant reductions in serum total cholesterol and triglyceride levels. 
Anti-miR-122 therapy resulted in a significant reduction in K-circulating cholesterol levels (25%-30%), suggesting that 
miR-122 may directly regulate cholesterol synthesis [7]. Chofit Chai [8] analyzed the activity of miR122 promoter, and 
verified its target mRNA by using luciferase reporter gene, and verified human AGPAT1 and DGAT1 mRNAs involved 
in triglyceride synthesis as miR-122 targets. Interestingly, miR-370 also affects lipid synthesis and has similar effects 
to miR-122. However, unlike miR-122, which directly regulates cholesterol synthesis, miR-370 plays a role mainly 
by modifying the expression of miR-122.In addition, miR-33a has also been proved to regulate cholesterol synthesis 
through targeting relationships [9].
Stearyl coenzyme A desaturase 1 (SCD-1) is A delta-9 fatty acid desaturase that catalyzed the synthesis of 
monounsaturated fatty acids [10].Cheng[11] verified the targeting of SCD-1 and miR-125b by bioinformatics analysis 
and dual luciferase method, and demonstrated the relationship between the targeting relationship of the two and lipid 
metabolism in vivo and in vitro. Overexpression of miR-125b decreased lipid droplets and triglyceride concentration 
accumulation, and inhibited SCD-1 protein expression and MUFA composition. The miR-125b inhibitor had the 
opposite effect. Small interfering RNAs tested in adipocytes further demonstrated a direct correlation between miR-125b 
and SCD-1.Himanshi Bhatia[12] showed that miR-107 inhibits fatty acid synthase FASN level by binding to its 3’UTR, 
and this interaction promoted ER stress induction and lipid accumulation in HepG2 cells and primary liver cells.
LXR activates and induces the expression of adipogenic genes, thereby promoting hepatic steatosis and 
steatohepatitis. After RNA-seq, mass spectrometry and bioinformatics analysis, Lei Fan[13] explored the relationship 
between miR-552-3p and lipid metabolism through in vivo experiments, and the results showed that miR-552-3p 
in the nucleus could regulate the transcriptional activity of LXRα and regulate lipid metabolism by binding to the 
complementary sequence of AGGTCA. Zhong[14] also found that miR-1/miR-206 has a similar regulatory relationship 
with LXRα
3.	MiRNA	and	lipid	decomposition
Lipid decomposition refers to the oxidative decomposition of fatty acids, cholesterol and triglycerides in the body 
[15].Catabolism of triglycerides, also known as fat mobilization, refers to the breakdown of triglycerides into fatty acids 
and glycerol under the action of hormone-sensitive triglyceride lipases in adipocytes and their release into the blood 
for oxidation by other tissues. Oxidative decomposition of fatty acids [16] refers to the β-oxidation of various fatty acids 
in mitochondria directly or after oxidation. In addition, fatty acids can be eliminated by secreting them into plasma via 
very low-density lipoprotein (LDL), which is rich in triglycerides. The main metabolic way of cholesterol in the body is 
to produce bile acid through oxidation in the liver [17], which is excreted with bile, and the daily excretion accounts for 
about 40%-50% of cholesterol synthesis.
MiR-378/378* is highly expressed during adipogenesis. Zhang[18] found that miR-378 significantly increased in 
fatty liver of diet-obese mice and human hepatocellular carcinoma HepG2 cells with accumulated lipids. Further studies 
identified NRF1 (nuclear receptor factor 1) as a key regulator of fatty acid oxidation (FAO) and as a direct target of 
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miR-378.and its ASO (antisense oligonucleotide) knockdown of miR-378 improved FAO and reduced intracellular lipid 
content in HEPA1-6 cells.
Mattis [19] found that after injecting miR-29a antisense oligonucleotide in mice, triglyceride accumulation in liver 
increased, and after being treated with LPL antisense oligonucleotide, triglyceride accumulation decreased, suggesting 
that miR-29a may reduce triglyceride accumulation by inhibiting LPL. After miR-29a was inhibited, the expression 
levels of LPLmRNA and protein were significantly increased, and the accumulation of triglyceride and cholesterol 
were significantly increased, suggesting the relationship between the binding of miR-29a and LPLmRNA and lipid 
decomposition in fatty liver mice. It is worth mentioning that Yang[20] found that miR-29b homologous to miR-29a also 
has a similar effect in binding to LPL targeting.
MiR-122 is not only involved in the synthesis of cholesterol in liver, but also closely related to the oxidative 
decomposition of fatty acids. Inhibition of miR-122 expression could enhance the activity of PMVK, increase the 
β-oxidation of fatty acids and promote the decomposition of fatty acids. Gatfield [21] indicated that miR-122 can 
directly act on peroxisomal proliferator-activated receptor genes, which can be activated by fatty acids and exogenous 
peroxisomal proliferators to regulate the expression of enzymes involved in fatty acid decomposition and participate 
in fatty acid metabolism. After knockout of miR-122, PPARβ protein level was significantly increased and fatty acid 
content was decreased. Similarly, miR-30b [22] has also been proved to be involved in lipid decomposition and also acts 
on peroxisome proliferator-activated receptor genes.
4.	MiRNAs	and	lipid	transfer
Microsomal triglyceride transfer protein (MTP) was first identified as an endoplasmic reticulum (ER) resident 
protein that helps transfer neutral lipids to neonatal apolipoprotein B(ApoB)[34-36].ApoB-containing lipoproteins are 
macromolecular lipids and protein micelles that can be used as specialized transport vehicles for hydrophobic lipids.The 
secretion of lipoprotein into circulation is conducive to reducing lipid accumulation in tissues or organs [23].
Zhang [24] observed that the overexpression of miR-130b in HepG2 cells significantly enhanced the secretion of 
very low-density lipoprotein (VLDL) particles, enhanced glycerol metabolism-labeled triglyceride (TG), respectively. 
The over- expression of miR-130b significantly increased the mRNA and protein expression levels of microsomal 
triglyceride transfer protein (MTP). These results suggest that miR-130b has a potential role in promoting hepatic VLDL 
assembly and secretion by significantly stimulating MTP expression and TG mobilization.
Ma[25] verified the targeting relationship between microRNA-101-2-5p and ApoB by database target prediction and 
dual luciferase reporter gene, and analyzed the effect of miRNA on the expression of ApoB in 17β-estradiol-stimulated 
chicken embryo hepatocytes. Bioinformatics algorithm showed that there were two potential binding sites of miR-548p 
on human ApoB mRNA, and Zhou[26] cotransfected with miR-548p,After a series of verifications such as site-directed 
mutagenesis, it was also confirmed that miR-548p interacted with the 3’ -untranslated region of human ApoB mRNA 
to enhance transcription. James Soh[27.28] demonstrated that miR-30c regulates the assembly and secretion of ApoB 
lipoproteins by regulating MTP activity, and this regulation requires interactions between miR-30c and MTP genes, 
including seed and complementary sequences [29].However, it is worth mentioning that other members of the miR-30 
family are not targeted at MTP because they do not form the same complementary interactions.
Adenosine triphosphate binding box transporter A1(ABCA1) is a key transporter for cholesterol reversal. 
Bioinformatics analysis of the target ABCA1-3’UTR was conducted to search for conserved miRNAs, and it was found 
that miR-106b [30] could target ABCA1 binding. Moreover, in neural cell lines, miR-106b can reduce cholesterol flow 
to apoAI under both physiological and LXR stimulation. In addition, Zhisheng Wang et al. [31] detected 9 candidate 
differential miRNAs in plasma exosomes of 42 patients with coronary atherosclerosis, and found higher expression of 
miR-30e and miR-92a in the patients. After bioinformatics analysis and confirmation, It was proved that ATP binding 




In general, the regulation of lipid metabolism by miRNAs is a complex network regulation process, with 
overlapping targeting sites among different miRNAs, and related mechanisms of action involve the synthesis, 
metabolism and transformation of lipids such as cholesterol, triglyceride and fatty acids. The regulation of miRNAs on 
lipid metabolism is no single, but multi-directional. A miRNA has several target genes, and a gene may be regulated 
by multiple miRNAs simultaneously. MiRNAs constitute an extremely complex regulatory network in vivo, and 
these phenomena can reduce the importance of specific miRNAs in normal cell homeostasis. From the perspective 
of evolution, miRNA plays a role in regulating gene mutation during evolution, and its main role may be to “fine-
tune” gene expression. However, even though miRNA has limited effect on many target mRNAs, the superposition of 
regulatory factors of the same biological process can result in enhanced expression of a phenotype. The complexity of 
miRNAs not only adds another layer of complexity to the molecular causes of modern human disease, but also opens up 
the possibility of miRNA-based treatment of disease.
    There is no doubt about the role of miRNA in lipid metabolism. With the in-depth study of miRNAs, their 
regulation of lipid metabolism has been gradually revealed. At the same time, more and more miRNAs involved in the 
regulation of lipid metabolism pathway will be discovered. It provides a new idea for the treatment and prevention of 
many diseases.
Reference
[1] R.C. Lee, R.L. Feinbaum, V. Ambros, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense 
complementarity to lin-14, Cell, 75 (1993) 843-854.
[2] Y. Zhang, X. Wu, C. Liang, P. Bao, X. Ding, M. Chu, C. Jia, X. Guo, P. Yan, MicroRNA-200a regulates adipocyte 
differentiation in the domestic yak Bos grunniens, Gene, 650 (2018) 41-48.
[3] A. Acharya, D.C. Berry, H. Zhang, Y. Jiang, B.T. Jones, R.E. Hammer, J.M. Graff, J.T. Mendell, miR-26 suppresses 
adipocyte progenitor differentiation and fat production by targeting Fbxl19, Genes Dev, 33 (2019) 1367-1380.
[4] J. Xu, microRNA-16-5p promotes 3T3-L1 adipocyte differentiation through regulating EPT1 Biochem Biophys Res 
Commun. 2019 Jul 5;514(4):1251-1256.
[5] Y. Zhang, X. Wu, C. Liang, P. Bao, X. Ding, M. Chu, C. Jia, X. Guo, P. Yan, MicroRNA-200a regulates adipocyte 
differentiation in the domestic yak Bos grunniens, Gene, 650 (2018) 41-48.
[6] M. Alves-Bezerra, D.E. Cohen, Triglyceride Metabolism in the Liver, Compr Physiol, 8 (2017) 1-8.
[7] W.C. Tsai, S.D. HsuMicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis, J Clin Invest, 
122 (2012) 2884-2897.
[8] C. Chai, M. Rivkin, L. Berkovits, A Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride 
Synthesis in Liver and Muscle Tissues, Gastroenterology, 153 (2017) 1404-1415.
[9] F. Kostopoulou, K.N. Malizos, I. Papathanasiou, A. Tsezou, MicroRNA-33a regulates cholesterol synthesis and cho-
lesterol efflux-related genes in osteoarthritic chondrocytes, Arthritis Res Ther, 17 (2015) 42.
[10] C.M. Paton, J.M. Ntambi, Biochemical and physiological function of stearoyl-CoA desaturase, Am J Physiol Endo-
crinol Metab, 297 (2009) E28-37.
[11] X. Cheng, Q.Y. Xi, S. Wei, D. Wu, R.S. Ye, T. Chen, Q.E. Qi, Q.Y. Jiang, S.B. Wang, L.N. Wang, X.T. Zhu, Y.L. 
Zhang, Critical role of miR-125b in lipogenesis by targeting stearoyl-CoA desaturase-1 (SCD-1), J Anim Sci, 94 
(2016) 65-76.
[12] H. Bhatia, G. Verma, M. Datta, miR-107 orchestrates ER stress induction and lipid accumulation by post-transcrip-
tional regulation of fatty acid synthase in hepatocytes, Biochim Biophys Acta, 1839 (2014) 334-343.
[13] L. Fan, R. Lai, N. Ma, Y. Dong miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate he-
2021 | Volume 10 | Issue 3 -27-
patic glycolipid metabolism disorder, J Hepatol, 74 (2021) 8-19.
[14] D. Zhong, MicroRNA-1 and microRNA-206 suppress LXRα-induced lipogenesis in hepatocytes Cell Signal. 2013 
Jun;25(6):1429-37
[15] R. Zechner, R. Zimmermann, T.O. Eichmann, S.D. Kohlwein, G. Haemmerle, A. Lass, F. Madeo, FAT SIG-
NALS--lipases and lipolysis in lipid metabolism and signaling, Cell Metab, 15 (2012) 279-291.
[16] E. Tvrzicka, Fatty acids as biocompounds: their role in human metabolism, health and disease--a review. Part 1: 
classification, dietary sources and biological functions Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 
2011 Jun;155(2):117-30.
[17] T.Q. de Aguiar Vallim, E.J. Tarling, P.A. Edwards, Pleiotropic roles of bile acids in metabolism, Cell Metab, 17 
(2013) 657-669.
[18] T. Zhang, A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteato-
sis in mice treated with a high fat diet Metabolism. 2018 Aug; 85:183-191.
[19] A.N. Mattis, A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid 
distribution away from the liver Hepatology. 2015 Jan;61(1):141-52, 2015.
[20] Y. Yang, Q. Pan, B. Sun, R. Yang, X. Fang, X. Liu, X. Yu, Z. Zhao, miR-29b Targets LPL and TDG Genes and 
Regulates Apoptosis and Triglyceride Production in MECs, DNA Cell Biol, 35 (2016) 758-765.
[21] D. Gatfield, G. Le Martelot, C.E. Vejnar, D. Gerlach, O. Schaad, F. Fleury-Olela, A.L. Ruskeepaa, M. Oresic, C.C. 
Esau, E.M. Zdobnov, U. Schibler, Integration of microRNA miR-122 in hepatic circadian gene expression, Genes 
Dev, 23 (2009) 1313-1326.
[22] Q. Zhang, X.F. Ma, M.Z. Dong, J. Tan, J. Zhang, L.K. Zhuang, S.S. Liu, Y.N. Xin, MiR-30b-5p regulates the lipid 
metabolism by targeting PPARGC1A in Huh-7 cell line, Lipids Health Dis, 19 (2020) 76.
[23] A. Sirwi, M.M. Hussain, Lipid transfer proteins in the assembly of apoB-containing lipoproteins, J Lipid Res, 59 
(2018) 1094-1102.
[24] J.Z.F.R. JaziI, miR-130b is a potent stimulator of hepatic very-low-density lipoprotein assembly and secretion 
via marked induction of microsomal triglyceride transfer protein Am J Physiol Endocrinol Metab. 2020 Feb 
1;318(2):E262-E275., 2020.
[25] Z. Ma, H. Li, H. Zheng, K. Jiang, L. Jia, F. Yan, Y. Tian, X. Kang, Y. Wang, X. Liu, MicroRNA-101-2-5p targets 
the ApoB gene in the liver of chicken (Gallus Gallus), Genome, 60 (2017) 673-678.
[26] L.Zhou, M.M. Hussain, Human MicroRNA-548p Decreases Hepatic Apolipoprotein B Secretion and Lipid Syn-
thesis, Arterioscler Thromb Vasc Biol, 37 (2017) 786-793.
[27] J. Soh, J. Iqbal, J. Queiroz, C. Fernandez-Hernando, M.M. Hussain, MicroRNA-30c reduces hyperlipidemia and 
atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion, Nat Med, 19 (2013) 892-900.
[28] K.C. Vickers, K.J. Moore, Small RNA overcomes the challenges of therapeutic targeting of microsomal triglycer-
ide transfer protein, Circ Res, 113 (2013) 1189-1191.
[29] J. Soh, M.M. Hussain, Supplementary site interactions are critical for the regulation of microsomal triglyceride 
transfer protein by microRNA-30c, Nutr Metab (Lond), 10 (2013) 56.
[30] J. Kim, MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression Exp Neurol. 
2012 Jun;235(2):476-83.
[31] Z. Wang, MiR-30e and miR-92a are related to atherosclerosis by targeting ABCA1 Mol Med Rep. 2019 
Apr;19(4):3298-3304.
